US Patent 11,766,431 — assignment history and current owner

US 11,766,431 · Application 17/245,209

New Therapeutical Composition Containing Apomorphine As Active Ingredient

Who owns US Patent 11,766,431?

US11766431 ("New Therapeutical Composition Containing Apomorphine As Active Ingredient") — current assignee: BRITANNIA PHARMACEUTICALS LTD.. Status: Active, estimated expiration July 11, 2032. 1 recorded USPTO assignment.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 11,766,431 is BRITANNIA PHARMACEUTICALS LTD.. Based on the most recent ownership transfer record (recorded 2021-04-30).

Patent title
New Therapeutical Composition Containing Apomorphine As Active Ingredient
Application number
17/245,209
Apparent operating assignee
BRITANNIA PHARMACEUTICALS LTD.
Patent status
Active, estimated expiration July 11, 2032
Recorded assignments
1

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jan 27, 2014Apr 30, 2021Ownership TransferMONDOLY, NATHALIE; BERTOCCHI, LAURENT; HARNETT, JEREMIAH; RICHARD, JOEL; BARONNET, MARIE-MADELEINE; DEY, MICHAELBRITANNIA PHARMACEUTICALS LTD.56093/953

Scrolls sideways on narrow screens

Chain of title

In 2021, MONDOLY, NATHALIE; BERTOCCHI, LAURENT (+4 more) assigned the patent to BRITANNIA PHARMACEUTICALS LTD..

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 17/245,209 · US 11,766,431

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 11,766,431, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.